0
0
New Delhi, Sep 13, 2025 – As India marks Childhood Cancer Awareness Month, healthcare experts are raising the alarm on the rising incidence of childhood cancers in the country, estimated at 50,000 to 75,000 new cases annually. Pediatric oncologists and geneticists are urging parents and caregivers to remain vigilant for early symptoms to facilitate timely diagnosis and treatment, which can significantly improve survival outcomes.
Key Findings and Developments
According to the National Cancer Registry Programme (NCRP) data from 2012 to 2016, cancers in children aged 0 to 14 years constitute about 4% of all cancer cases in India. The incidence rates are particularly high in urban centers such as Delhi, where adjusted incidences reach up to 203.1 per million in boys and 125.4 per million in girls. Leukemia, lymphoma, and central nervous system (CNS) tumors are the most common cancer types among children in India. Leukemia, a cancer of the blood, accounts for nearly one-third of childhood cancer cases with acute lymphoblastic leukemia (ALL) being the predominant subtype. CNS tumors, including brain and spinal cord cancers, form the second-largest group, followed by lymphomas and solid tumors like neuroblastoma and Wilms tumor.
Dr. Annie Q Hasan, Head of Genetics and Molecular Medicine at a private hospital, explains that genetic predispositions play a critical role in childhood cancers, citing inherited conditions such as Neurofibromatosis, Retinoblastoma, Beckwith-Wiedemann syndrome, Fanconi anemia, Li-Fraumeni syndrome, Von Hippel-Lindau disease, and Down syndrome. These syndromes increase the risk for mutations or chromosomal abnormalities that can trigger cancer development.
Dr. Kanchan S Channawar, Consultant Pediatrician and Intensivist, adds that some cancerous cells may start forming even before birth during fetal development. “The faster these abnormal cells multiply, the earlier cancer manifests in children. Fortunately, younger patients tend to respond better to chemotherapy and have faster recovery rates compared to adults,” she noted.
Context and Background Information
Childhood cancers are biologically different from adult cancers and their causes are not fully understood. Unlike adult cancers, lifestyle factors play a much smaller role. Instead, genetic mutations, prenatal exposure to harmful radiation, drugs, environmental pollutants, infections such as the Epstein-Barr virus (EBV), immune system disorders, and parental lifestyle habits contribute to cancer risk.
The NCRP and other registries have highlighted that India’s reported incidence of childhood cancers remains lower than that of high-income countries, a discrepancy likely due to underdiagnosis and underreporting given limited diagnostic resources, socioeconomic barriers, and lack of awareness. These gaps underscore the importance of strengthening diagnostic infrastructure and raising public awareness to ensure earlier detection and prompt interventions.
Implications for Public Health
Early recognition of warning signs is crucial to improving survival and quality of life for children diagnosed with cancer. Common symptoms include unexplained persistent fever, loss of appetite, significant weight loss, joint or bone pain, headaches, abdominal discomfort, swollen lymph nodes, and pale skin.
Timely genetic testing can help identify children at elevated risk, enabling closer surveillance and early treatment. Advances in genetic research have illuminated how certain inherited mutations or structural variants increase susceptibility, accounting for an estimated 8% to 10% of childhood cancers. This knowledge may pave the way for targeted therapies that minimize the harsh side effects associated with conventional chemotherapy and radiation.
Despite these advances, childhood cancer outcomes in India remain challenging due to healthcare access disparities. Nevertheless, treatment improvements have significantly increased survival rates worldwide. For example, five-year survival rates for childhood acute lymphoblastic leukemia have risen from about 60% in the 1970s to over 85% today internationally, with similar gains seen in India’s specialized centers.
Potential Limitations and Counterarguments
While genetic and environmental factors are acknowledged contributors, the exact causes of most childhood cancers remain elusive. Some experts caution against overemphasis on genetic predisposition alone, highlighting the multifactorial nature of cancer and the need to consider broader environmental and social determinants.
Additionally, early symptoms of childhood cancer often overlap with common childhood illnesses, which can delay diagnosis. Increasing physician awareness, along with parental education, is vital to improving early detection without causing undue alarm.
Expert Perspectives
“Raising awareness among parents and healthcare professionals about early warning signs is essential to catching pediatric cancers in their initial stages, when treatment outcomes are much better,” said Dr. Riaz Gillani, Pediatric Oncologist at Dana-Farber Cancer Institute. He added that ongoing research into genetic factors will help tailor treatments to individual patients, reducing toxic side effects.
Dr. Annie Q Hasan emphasized the importance of comprehensive healthcare approaches that combine genetic testing, environmental risk reduction, and public education. “India requires coordinated efforts to improve childhood cancer registries, diagnostic services, and affordable treatment options nationwide,” she said.
Practical Implications for Readers
Parents should monitor their child’s health vigilantly and seek prompt medical advice if symptoms persist beyond common illnesses. Awareness of family history and known genetic conditions can inform discussions with healthcare providers about screening options.
Healthcare systems must prioritize childhood cancer infrastructure, making advanced diagnostics and treatment accessible beyond urban centers. Meanwhile, policymakers can support awareness campaigns and research funding to bridge gaps in care.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
